FDA 483 - Takeda Manufacturing Singapore Pte. Ltd. - August 15, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Takeda Manufacturing Singapore Pte. Ltd., a licensed biological drug manufacturer, received a Form 483 for significant deficiencies observed during an FDA inspection. The firm was cited for inadequate investigations into manufacturing deviations, failures in validating manufacturing processes and cleaning procedures, and critical shortcomings within the quality unit, including a lack of written procedures and insufficient training oversight. These issues resulted in the release of impacted drug substance batches to the U.S. market and identified contamination risks.
ID · 28dfd9c1-4e7f-41ae-b111-b3c9e4354d10